Clinically, the presence of plasmatic VEGFXXX/NF correlates with poor prognosis in metastatic ccRCC, which is consistent with the effect of VEGFXXX/NF in experimental tumours. This evidence concerns the gene NFASC and nonpapillary renal cell carcinoma.